OPEN ACCESS: BENEFITS

Benefits to researchers, institutions, nations & Society as whole.

For researchers, increased visibility raising impact factor.

Benefit for researchers who can’t pay for paper subscription.

As in today’s era of internet its free to access research articles on related latest researches to researchers & Scholars.

CHEMOTHERAPY: OPEN ACCESS

ISSN:2167-7700

Chemotherapy deals with the study &

treatment of diseases using chemical

agents/drugs, that are selectively toxic to the

causative agent of the disease.

Make the research work freely accessible

globally through internet to share the

innovations of the researchers to scientific

community.

Chemotherapy aims to provide current

events, advantages and limitations in the

field of chemotherapy.

Chemotherapy: Open Access consists of

43 well qualified EB members throughout the

world mostly from USA, Japan, UK and some

other countries

EB MEMBER CATEGORISATION

Cancer Chemotherapy

17%

Chemotherapeutic Agents

17%

Chemotherapy Drugs12%

Chemotherapy: Treatment & Side effects

10%

Immunochemotherapy14%

Target for Chemotherapy

15%

Others15%

Percentage

JOURNAL STATUS

Started in 2011

Released first issue in March 2012

Recently Released Vol. 2, Issue 3

Releasing Vol 3, Issue 1 in Feb 2013

27

27.5

28

28.5

29

29.5

30

Recieved Accepted Published

No. Of Articles 30 29 28

No

of

Art

icle

sJOURNAL STATUS

FUNDING ARTICLES

1 article funded by Japan Society for the

Promotion of Science and Smoking

Research Foundation.

Above 90% from high income country

Journal of Cancer Science & Therapy

Journal of Carcinogenesis & Mutagenesis

JCST started in 2009, Currently Vol 5, Issue 2

JCM started in 2010, Currently Vol. 3,Issue 2

RELATED JOURNALS FROM OTHER SOURCE

Journal of Chemotherapy (Maney Publishing)

Journal of Infection and Chemotherapy

(Springer)

Journal of chemotherapy (ResearchGate)

Journal of Antimicrobial Chemotherapy

(Oxford Journals)

International Journal Of Experimental &

Clinical Chemotherapy (Karger)

Two Special Issues has been approved for

Chemotherapy

Translational Pathology

Immunochemotherapy

RELATED CONFERENCES

Optimizing Outcomes in Colorectal Cancer Boston, United States of America, 7th Feb 2013.

CHI's Targeting Cancer Stem Cells San Francisco, United States of America, 11th Feb 2013.

16thScripps Cancer Center's 33rd Annual Clinical Hematology and Oncology Conference San Diego, United States of America, 16th Feb 2013.

2nd Novel Cancer Therapeutics Summit Las Vegas, United States of America, 25th Feb 2013.

24th Annual Cancer Progress Conference New York, United States of America, 5th March 2013

7th Conference on Experimental and Translational Oncology -

CETO Portoroz, Slovenia, 20th April 2013.

British Gynaecological Cancer Society Annual Scientific

Meeting Belfast , Ireland, 20th June 2013.

MASCC/ISOO 2013 International Cancer Care

Symposium Berlin, Germany, 27th June 2013.

27th17th ECCO - 38th ESMO - 32nd ESTRO European Cancer

Congress Amsterdam, Netherlands, 27th Sep 2013.

TO ADVERTISE THE JOURNAL AT CONFERENCES

Firstly advertise on the conference

website by placing banner ads with a

link to our website.

At the conference venue placing our

banners

Make use of pamphlets, Journal Digital

file to explain about our journals scope.

Inviting researchers attending related

conference by invitation letter and

pamphlets

INDEXING

It shows our table of content and abstracts

included in various online collections.

It increases visibility of our journal & perceived

quality of our journal.

It increases the ability to be searched for

information among various other publications.

INDEXING OF THE JOURNAL

Chemotherapy is indexed in

Google Scholar

OARE

Open J-Gate

DOAJ

COPERNICUS

SCRIUS

PLAN FOR INDEXING IN SCOPUS,MEDLINE,ISI

Issue release at regular interval.

Send invitations to quality person having

relevant field of interest as per the journal.

Coin special issue topics on recent ongoing

researches.

Updates EB profile every month based on

their designation, research interest etc.

Provide variable fee for different countries.

Gentle and polite communication in a professional way with the researchers.

Form your own words at different situations or for replies instead of same type of communication to gain interest from contributors.

Regular communication with EB members and researchers for their suggestions and contributors.

Updating status of EB member in website

regarding their designation, research

interest and ongoing projects, thus by

communicating regularly to gain interest

from them.

Accepting quality paper regardless of

country.

Providing variable fee for different

countries.

CONTACT US

Articles can be submitted to

editor.cmt@omicsonline.org

or

http://omicsgroup.org/editorialtracking/chemotherapy/SubmitManuscript.php

Website:

http://www.omicsgroup.org/journals/cmthome.php